|
1
|
|
$91.9M
|
+$12.6M
|
+599,805
|
+14%
|
|
|
2
|
Point72 Asset Management
Stamford,
Connecticut
|
$79.9M
|
+$9.25M
|
+440,186
|
+12%
|
|
|
3
|
State Street
Boston,
Massachusetts
|
$57.5M
|
+$14.7M
|
+698,121
|
+30%
|
|
|
4
|
Nantahala Capital Management
New Canaan,
Connecticut
|
$54.4M
|
-$3.97M
|
-188,828
|
-6%
|
|
|
5
|
Fidelity Investments
Boston,
Massachusetts
|
$51.1M
|
-$1.3M
|
-61,926
|
-2%
|
|
|
6
|
PFM Health Sciences
San Francisco,
California
|
$44.9M
|
+$3.3M
|
+156,941
|
+7%
|
|
|
7
|
|
$30M
|
+$15.2M
|
+722,151
|
+83%
|
|
|
8
|
Vanguard Group
Malvern,
Pennsylvania
|
$26.9M
|
+$2.97M
|
+141,382
|
+11%
|
|
|
9
|
683 Capital Management
New York
|
$25.8M
|
+$391K
|
+18,600
|
+1%
|
|
|
10
|
Holocene Advisors
New York
|
$25.7M
|
+$14.5M
|
+688,379
|
+101%
|
|
|
11
|
|
$18.5M
|
-$7.18M
|
-341,409
|
-26%
|
|
|
12
|
Aquilo Capital Management
San Francisco,
California
|
$15.8M
|
-$2.73M
|
-130,019
|
-13%
|
|
|
13
|
|
$13.8M
|
-$1.48M
|
-70,309
|
-9%
|
|
|
14
|
Macquarie Group
Sydney, NSW 2000,
Australia
|
$13.3M
|
-$13.3K
|
-631
|
-0.1%
|
|
|
15
|
|
$11.6M
|
+$5.45M
|
+259,000
|
+72%
|
|
|
16
|
International Biotechnology Trust
London,
United Kingdom
|
$10.2M
|
+$11.3M
|
+536,182
|
+6,446%
|
|
|
17
|
Tekla Capital Management
Boston,
Massachusetts
|
$9.79M
|
–
|
–
|
–
|
|
|
18
|
Ameriprise
Minneapolis,
Minnesota
|
$9.48M
|
+$545K
|
+25,917
|
+5%
|
|
|
19
|
|
$8.83M
|
+$1.42M
|
+67,551
|
+17%
|
|
|
20
|
Adage Capital Partners
Boston,
Massachusetts
|
$8.54M
|
+$4.84M
|
+230,000
|
+102%
|
|
|
21
|
Integral Health Asset Management
New York
|
$8.12M
|
+$1.68M
|
+79,894
|
+23%
|
|
|
22
|
Geode Capital Management
Boston,
Massachusetts
|
$7.43M
|
+$788K
|
+37,480
|
+10%
|
|
|
23
|
Bank of New York Mellon
New York
|
$6.25M
|
+$1.14M
|
+54,376
|
+19%
|
|
|
24
|
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$6.2M
|
-$2.45M
|
-116,397
|
-26%
|
|
|
25
|
AllianceBernstein
Nashville,
Tennessee
|
$6.12M
|
-$3.76M
|
-178,888
|
-35%
|
|
